
Opinion|Videos|May 15, 2024
FDA-approved Therapies for Geographic Atrophy
An expert retina specialist discusses the recent FDA-approved treatments for geographic atrophy (GA) that slow disease progression and highlights key factors to consider before starting treatment.
Advertisement
Newsletter
Keep your retina practice on the forefront—subscribe for expert analysis and emerging trends in retinal disease management.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Modern Retina
1
Timely interventions can protect vision in patients with GA
2
Enhancing Durability and Fluid Control with Aflibercept 8 mg in Retinal Vascular Diseases
3
Aviceda Therapeutics reports positive phase 2b SIGLEC results for AVD-104 in geographic atrophy
4
Evolving Therapeutic Strategies with Next-Generation Anti-VEGF Agents in Retinal Vascular Diseases
5










































